OSAKA, Japan--(BUSINESS WIRE)--In 2013, Glico conducted in vivo human clinical trials with Cluster Dextrin® (Highly Branched Cyclic Dextrin / HBCD). The attendant theses were reviewed, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback